|
FORM
10-Q
|
|
[X]
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
For
the quarterly period ended April 1, 2007
|
|
or
|
|
[
]
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
For
the transition period from ________________ to
_______________________
|
Commission
file number 1-4347
|
ROGERS
CORPORATION
|
(Exact
name of Registrant as specified in its
charter)
|
|
Massachusetts
|
06-0513860
|
(State
or other jurisdiction of
|
(I.
R. S. Employer
|
incorporation
or organization)
|
Identification
No.)
|
|
|
P.O.
Box 188, One Technology Drive, Rogers, Connecticut
|
06263-0188
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant's
telephone number, including area code: (860)
774-9605
|
Large
Accelerated Filer X
|
Accelerated
Filer ____
|
Non-accelerated
filer ____
|
TABLE
OF CONTENTS
|
||
Exhibits:
|
Exhibit
10r-8
|
Amendment
No. 8 to Summary of Director and Executive Officer
Compensation
|
||
Exhibit
10aac
|
Form
of Nonqualified Stock Option Agreement (for Key Employees, with
vesting)
under the Rogers
Corporation 1990 Stock Option Plan, as amended
|
||
Exhibit
23.1
|
Consent
of National Economic Research Associates, Inc.
|
||
Exhibit
23.2
|
Consent
of Marsh, U.S.A.
|
||
Exhibit
31(a)
|
Certification
of President and CEO Pursuant to Section 302 of the Sarbanes-Oxley
Act of
2002
|
||
Exhibit
31(b)
|
Certification
of Vice President, Finance and CFO Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
||
Exhibit
32
|
Certification
of President and CEO and Vice President, Finance and CFO Pursuant
to
Section 906 of the Sarbanes-Oxley Act of 2002
|
||
|
Three
Months Ended
|
||||||
|
April
1,
2007
|
April
2,
2006
|
|||||
Net
sales
|
$
|
115,846
|
$
|
103,131
|
|||
Cost
of sales
|
80,648
|
66,844
|
|||||
Gross
margin
|
35,198
|
36,287
|
|||||
Selling
and administrative expenses
|
19,291
|
17,385
|
|||||
Research
and development expenses
|
5,688
|
5,961
|
|||||
Operating
income
|
10,219
|
12,941
|
|||||
Equity
income in unconsolidated joint ventures
|
1,268
|
2,889
|
|||||
Other
income (expense), net
|
587
|
(17
|
)
|
||||
Interest
income, net
|
425
|
350
|
|||||
Income
before income taxes
|
12,499
|
16,163
|
|||||
Income
tax expense
|
2,988
|
3,556
|
|||||
Net
income
|
$
|
9,511
|
$
|
12,607
|
|||
Net
income per share:
|
|||||||
Basic
|
$
|
0.56
|
$
|
0.76
|
|||
Diluted
|
0.54
|
0.74
|
|||||
Shares
used in computing:
|
|||||||
Basic
|
16,834,431
|
16,486,068
|
|||||
Diluted
|
17,646,551
|
16,928,026
|
|||||
|
April
1,
2007
|
December
31,
2006
|
|||||
Assets
|
|||||||
Current
assets
|
|||||||
Cash
and cash equivalents
|
$
|
23,078
|
$
|
13,638
|
|||
Short-term
investments
|
37,730
|
68,185
|
|||||
Accounts
receivable, less allowance for doubtful accounts of $1,968 and
$2,024
|
85,216
|
86,311
|
|||||
Accounts
receivable from joint ventures
|
4,669
|
5,437
|
|||||
Accounts
receivable, other
|
2,129
|
3,552
|
|||||
Note
receivable
|
2,100
|
2,100
|
|||||
Inventories
|
71,508
|
70,242
|
|||||
Deferred
income taxes
|
17,075
|
15,430
|
|||||
Asbestos-related
insurance receivables
|
4,244
|
4,244
|
|||||
Other
assets
|
6,221
|
3,415
|
|||||
Total
current assets
|
253,970
|
272,554
|
|||||
Property,
plant and equipment, net of accumulated depreciation of
$143,399 and $141,490
|
143,207
|
141,728
|
|||||
Investments
in unconsolidated joint ventures
|
26,174
|
26,629
|
|||||
Deferred
income taxes
|
6,690
|
4,828
|
|||||
Pension
asset
|
974
|
974
|
|||||
Goodwill
|
10,656
|
10,656
|
|||||
Other
intangible assets
|
339
|
454
|
|||||
Asbestos-related
insurance receivables
|
18,503
|
18,503
|
|||||
Other
assets
|
4,522
|
4,576
|
|||||
Total
assets
|
$
|
465,035
|
$
|
480,902
|
|||
Liabilities
and Shareholders’ Equity
|
|||||||
Current
liabilities
|
|||||||
Accounts
payable
|
$
|
17,791
|
$
|
25,715
|
|||
Accrued
employee benefits and compensation
|
14,633
|
27,322
|
|||||
Accrued
income taxes payable
|
17,794
|
9,970
|
|||||
Asbestos-related
liabilities
|
4,244
|
4,244
|
|||||
Other
accrued liabilities
|
16,942
|
14,892
|
|||||
Total
current liabilities
|
71,404
|
82,143
|
|||||
Pension
liability
|
11,698
|
11,698
|
|||||
Retiree
health care and life insurance benefits
|
10,021
|
10,021
|
|||||
Asbestos-related
liabilities
|
18,694
|
18,694
|
|||||
Other
liabilities
|
997
|
1,169
|
|||||
Shareholders’
Equity
|
|||||||
Capital
Stock - $1 par value; 50,000,000 authorized shares; 16,685,568
and
16,937,523
shares issued and outstanding
|
16,686
|
16,938
|
|||||
Additional
paid-in capital
|
49,484
|
59,352
|
|||||
Retained
earnings
|
284,170
|
277,442
|
|||||
Accumulated
other comprehensive income
|
1,881
|
3,445
|
|||||
Total
shareholders' equity
|
352,221
|
357,177
|
|||||
Total
liabilities and shareholders' equity
|
$
|
465,035
|
$
|
480,902
|
|||
|
April
1,
2007
|
April
2,
2006
|
|||||
Operating
Activities
|
|||||||
Net
income
|
$
|
9,511
|
$
|
12,607
|
|||
Adjustments
to reconcile net income to cash provided by operating
activities:
|
|||||||
Depreciation
and amortization
|
5,352
|
5,347
|
|||||
Stock-based
compensation expense
|
2,635
|
516
|
|||||
Excess
tax benefit related to stock award plans
|
(170
|
)
|
(2,109
|
)
|
|||
Deferred
income taxes
|
(3,507
|
)
|
1,956
|
||||
Equity
in undistributed income of unconsolidated joint ventures,
net
|
(1,268
|
)
|
(2,889
|
)
|
|||
Dividends
received from unconsolidated joint ventures
|
1,138
|
784
|
|||||
Pension
and postretirement benefits
|
-
|
(1,780
|
)
|
||||
Other,
net
|
(307
|
)
|
501
|
||||
Changes
in operating assets and liabilities excluding effects of acquisition
and disposition of businesses:
|
|||||||
Accounts
receivable
|
3,452
|
(6,859
|
)
|
||||
Inventories
|
(1,020
|
)
|
(8,428
|
)
|
|||
Other
current assets
|
(2,797
|
)
|
(388
|
)
|
|||
Accounts
payable and other accrued liabilities
|
(13,612
|
)
|
8,683
|
||||
Net
cash (used in) provided by operating activities
|
(593
|
)
|
7,941
|
||||
Investing
Activities
|
|||||||
Capital
expenditures
|
(7,719
|
)
|
(2,367
|
)
|
|||
Proceeds
(Purchase) from short-term investments
|
30,473
|
(7,161
|
)
|
||||
Net
cash provided by (used in) investing activities
|
22,754
|
(9,528
|
)
|
||||
Financing
Activities
|
|||||||
Proceeds
from sale of capital stock, net
|
621
|
10,150
|
|||||
Excess
tax benefit related to stock award plans
|
170
|
2,109
|
|||||
Proceeds
from issuance of shares to employee stock purchase plan
|
381
|
473
|
|||||
Purchase
of stock
|
(13,937
|
)
|
-
|
||||
Net
cash (used in) provided by financing activities
|
(12,765
|
)
|
12,732
|
||||
Effect
of exchange rate fluctuations on cash
|
44
|
368
|
|||||
Net
increase in cash and cash equivalents
|
9,440
|
11,513
|
|||||
Cash
and cash equivalents at beginning of year
|
13,638
|
46,401
|
|||||
Cash
and cash equivalents at end of quarter
|
$
|
23,078
|
$
|
57,914
|
|||
Supplemental
disclosure of noncash investing activities
|
|||||||
Contribution
of shares to fund employee stock purchase plan
|
$
|
492
|
$
|
467
|
|||
(Dollars
in thousands)
|
April
1,
2007
|
December
31,
2006
|
|||||
Raw
materials
|
$
|
15,544
|
$
|
16,170
|
|||
Work-in-process
|
10,781
|
8,201
|
|||||
Finished
goods
|
45,183
|
45,871
|
|||||
$
|
71,508
|
$
|
70,242
|
||||
(Dollars
in thousands)
|
April
1,
2007
|
April
2,
2006
|
|||||
Net
income
|
$
|
9,511
|
$
|
12,607
|
|||
Foreign
currency translation adjustments
|
(1,564
|
)
|
2,608
|
||||
Comprehensive
income
|
$
|
7,947
|
$
|
15,215
|
|||
(Dollars
in thousands)
|
April
1,
2007
|
December
31,
2006
|
|||||
Foreign
currency translation adjustments
|
$
|
11,758
|
$
|
13,322
|
|||
Funded
status of pension plans and other postretirement benefits
|
(9,877
|
)
|
(9,877
|
)
|
|||
Accumulated
other comprehensive income
|
$
|
1,881
|
$
|
3,445
|
|||
(Dollars
in thousands, except per share amounts)
|
Three
Months Ended
|
||||||
|
April
1, 2007
|
April
2, 2006
|
|||||
Numerator:
|
|||||||
Net
Income
|
$
|
9,511
|
$
|
12,607
|
|||
|
|||||||
Denominator:
|
|||||||
Denominator
for basic earnings per share - Weighted-average shares
|
16,834,431
|
16,486,068
|
|||||
|
|||||||
Effect
of dilutive stock options
|
812,120
|
441,958
|
|||||
Denominator
for diluted earnings per share - Adjusted weighted—average shares and
assumed conversions
|
17,646,551
|
16,928,026
|
|||||
Basic
earnings per share
|
$
|
0.56
|
$
|
0.76
|
|||
Diluted
earnings per share
|
$
|
0.54
|
$
|
0.74
|
Three
months ended
|
|||||||
|
|
April
1,
2007
|
April
2,
2006
|
||||
Options
granted
|
207,150
|
145,250
|
|||||
Weighted
average exercise price
|
52.61
|
48.00
|
|||||
Weighted-average
grant date fair value
|
25.04
|
19.00
|
|||||
Assumptions:
|
|||||||
Expected
volatility
|
36.62
|
29.82
|
|||||
Expected
term (in years)
|
7.00
|
6.25
|
|||||
Risk-free
interest rate
|
4.72
|
%
|
4.60
|
%
|
|||
Expected
dividend yield
|
--
|
--
|
|
|
Options
Outstanding
|
|
Weighted-
Average
Exercise
Price
Per
Share
|
|
Weighted-
Average
Remaining
Contractual
Life
in Years
|
Aggregate
Intrinsic
Value
|
||||||
Options
outstanding at December 31, 2006
|
2,118,631
|
$
|
37.94
|
||||||||||
Options
granted
|
207,150
|
52.61
|
|||||||||||
Options
exercised
|
(25,499
|
)
|
24.98
|
||||||||||
Options
cancelled
|
(9,890
|
)
|
43.01
|
||||||||||
Options
outstanding at April 1, 2007
|
2,290,392
|
39.38
|
6.7
|
$
|
19,570,226
|
||||||||
Options
exercisable at April 1, 2007
|
1,897,369
|
37.17
|
6.2
|
19,359,293
|
|||||||||
Options
vested or expected to vest at April 1, 2007 (1)
|
2,273,815
|
$
|
39.35
|
6.7
|
$
|
19,485,262
|
|||||||
(1) |
In
addition to the vested options, the Company expects a portion of
the
unvested options to vest at some point in the future. Options expected
to
vest is calculated by applying an estimated forfeiture rate to the
unvested options.
|
(Dollars
in thousands)
|
Pension
Benefits
|
Retirement
Health and
Life
Insurance Benefits
|
||||||||||||
|
|
April
1,
2007
|
|
April
2,
2006
|
April
1,
2007
|
April
2,
2006
|
||||||||
Change
in benefit obligation:
|
||||||||||||||
Service
cost
|
$
|
1,153
|
$
|
1,185
|
$
|
207
|
$
|
188
|
||||||
Interest
cost
|
1,794
|
1,710
|
149
|
143
|
||||||||||
Expected
return on plan assets
|
(2,490
|
)
|
(2,137
|
)
|
-
|
-
|
||||||||
Amortization
of prior service cost
|
121
|
115
|
-
|
-
|
||||||||||
Amortization
of net loss
|
79
|
169
|
25
|
44
|
||||||||||
Net
periodic benefit cost
|
$
|
657
|
$
|
1,042
|
$
|
381
|
$
|
375
|
(Dollars
in thousands)
|
Three
Months Ended
|
||||||
April
1,
2007
|
April
2,
2006
(1)
|
||||||
Custom
Electrical Components
|
|||||||
Net
sales
|
$
39,264
|
$
28,785
|
|||||
Operating
income
|
3,136
|
1,048
|
|||||
Printed
Circuit Materials
|
|||||||
Net
sales
|
$
39,025
|
$
36,346
|
|||||
Operating
income
|
3,241
|
3,795
|
|||||
High
Performance Foams
|
|||||||
Net
sales
|
$
|
26,001
|
$
|
25,468
|
|||
Operating
income
|
3,968
|
6,109
|
|||||
Other
Polymer Products
|
|||||||
Net
sales
|
$
|
11,556
|
$
|
12,532
|
|||
Operating
(loss) income
|
(126
|
)
|
1,989
|
Joint
Venture
|
Location
|
Reportable
Segment
|
Fiscal
Year-End
|
Rogers
Inoac Corporation (RIC)
|
Japan
|
High
Performance Foams
|
October
31
|
Rogers
Inoac Suzhou Corporation (RIS)
|
China
|
High
Performance Foams
|
December
31
|
Rogers
Chang Chun Technology Co., Ltd. (RCCT)
|
Taiwan
|
Printed
Circuit Materials
|
December
31
|
Polyimide
Laminate Systems, LLC (PLS)
|
U.S.
|
Printed
Circuit Materials
|
December
31
|
(Dollars
in thousands)
|
April
1,
2007
|
April
2,
2006
|
|||||
Net
sales
|
$
|
22,104
|
$
|
30,088
|
|||
Gross
profit
|
4,063
|
9,998
|
|||||
Net
income
|
2,536
|
5,778
|
|||||
· |
Claims
|
· |
Defenses
|
· |
Dismissals
and Settlements
|
· |
Potential
Liability
|
· |
Insurance
Coverage
|
· |
Cost
Sharing Agreement
|
· |
Impact
on Financial Statements
|
Three
Months Ended
|
|||||||
April
1,
2007
|
April
2,
2006
|
||||||
Net
sales
|
100.0
|
%
|
100.0
|
%
|
|||
Manufacturing
margins
|
30.4
|
35.2
|
|||||
Selling
and administrative expenses
|
16.7
|
16.9
|
|||||
Research
and development expenses
|
4.9
|
5.8
|
|||||
Operating
profit
|
8.8
|
12.5
|
|||||
Equity
income in unconsolidated joint ventures
|
1.1
|
2.8
|
|||||
Other
income
|
0.9
|
0.3
|
|||||
Income
before income taxes
|
10.8
|
15.7
|
|||||
Income
taxes
|
2.6
|
3.4
|
|||||
Net
income
|
8.2
|
%
|
12.2
|
%
|
(Dollars
in millions)
|
Three
Months Ended
|
||||||
|
April
1,
2007
|
April
2,
2006
|
|||||
Net
sales
|
$
|
39.3
|
$
|
28.8
|
|||
Operating
income
|
3.1
|
1.0
|
(Dollars
in millions)
|
Three
Months Ended
|
||||||
|
April
1,
2007
|
April
2,
2006
|
|||||
Net
sales
|
$
|
39.0
|
$
|
36.3
|
|||
Operating
income
|
3.2
|
3.8
|
(Dollars
in millions)
|
Three
Months Ended
|
||||||
|
April,
1
2007
|
April
2,
2006
|
|||||
Net
sales
|
$
|
26.0
|
$
|
25.5
|
|||
Operating
income
|
4.0
|
6.1
|
(Dollars
in millions)
|
Three
Months Ended
|
||||||
April
1,
2007
|
April
2,
2006
|
||||||
Net
sales
|
$
|
11.6
|
$
|
12.5
|
|||
Operating
(loss) income
|
(0.1
|
)
|
2.0
|
(Dollars
in thousands)
|
April
1,
2007
|
December
31,
2006
|
|||||
Key
Balance Sheet Accounts:
|
|||||||
Cash,
cash equivalents and short-term investments
|
$
|
60,808
|
$
|
81,823
|
|||
Accounts
receivable
|
85,216
|
86,311
|
|||||
Inventory
|
71,508
|
70,242
|
|||||
|
Three
Months Ended
|
||||||
|
April
1,
2007
|
April
2,
2006
|
|||||
Key
Cash Flow Measures:
|
|||||||
Cash
(used in) provided by operating activities
|
$
|
(593
|
)
|
$
|
7,941
|
||
Cash
provided by (used in) investing activities
|
22,754
|
(9,528
|
)
|
||||
Cash
(used in) provided by financing activities
|
(12,765
|
)
|
12,732
|
o |
Short-term
investments decreased by $30.5 million from $68.2 million at December
31,
2006 to $37.7 million at April 1, 2007, as the proceeds were used
to
repurchase the Company’s common stock and pay the 2006 annual incentive
compensation awards.
|
o |
Accounts
payable decreased by $7.9 million from $25.7 million at December
31, 2006
to $17.8 million at April 1, 2007, primarily due to lower inventory
purchases during the later portion of the first quarter of
2007.
|
o |
Accrued
employee benefits and compensation decreased from $27.3 million at
December 31, 2006 to $14.6 million at April 1, 2007 due mainly to
the
payment of the 2006 annual incentive compensation awards paid in
the first
quarter of 2007.
|
o |
Shareholders
equity decreased by $5.0 million from $357.2 million at December
31, 2006
to $352.2 million at April 1, 2007 as a result of the common stock
repurchase and the FIN 48 adoption adjustment, partially offset by
current
period earnings.
|
Period
|
Total
Number of
Shares
Purchased
|
Average
Price
Paid
per Share
|
Total
Number of
Shares
Purchased
As
Part of Publicly
Announced
Plans
or
Programs
|
Approximate
Dollar
Value
of Shares that
May
Yet Be
Purchased
Under the
Plans
or Programs
|
|||||||||
January
1, 2007 through January 28, 2007
|
-
|
-
|
-
|
$
|
-
|
||||||||
January
29, 2007 through February 25, 2007
|
-
|
-
|
-
|
$
|
50,000,000
|
||||||||
February
26, 2007 through April 1, 2007
|
287,000
|
$
|
48.56
|
287,000
|
$
|
36,063,353
|
|||||||
Total
|
287,000
|
$
|
48.56
|
287,000
|
$
|
36,063,353
|
(a) |
Rogers’
Annual Meeting of Shareholders was held on April 26, 2007, during
the
second fiscal quarter of 2007.
|
(b) |
All
of the matters voted upon were approved and the specific votes are
as
follows:
|
Number
of Shares
|
||||
Name
|
For
|
Withheld
|
||
Leonard
M. Baker
|
14,891,610
|
1,135,175
|
||
Walter
E. Boomer
|
14,883,375
|
1,143,410
|
||
Charles
M. Brennan, III
|
14,959,121
|
1,067,664
|
||
Gregory
B. Howey
|
14,893,561
|
1,133,224
|
||
Leonard
R. Jaskol
|
14,862,446
|
1,164,339
|
||
Carol
R. Jensen
|
14,971,257
|
1,055,528
|
||
Eileen
S. Kraus
|
14,957,259
|
1,069,526
|
||
Robert
G. Paul
|
14,952,783
|
1,074,002
|
||
Robert
D. Wachob
|
14,897,810
|
1,128,975
|
Number
of Shares
|
||||
For
|
Against
|
Abstentions
|
||
16,001,685
|
19,718
|
5,382
|
2
|
Stock
Purchase Agreement, dated September 30, 2003, among 3M Company, 3M
Innovative Properties Company, Durel Corporation and Rogers Corporation
for the purchase of Durel Corporation was filed as Exhibit 2.1 to
the
Registrant’s Form 8-K filed on October 15, 2003*.
|
3a
|
Restated
Articles of Organization of Rogers Corporation were filed as Exhibit
3a to
the Registrant’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2006 filed on February 27, 2007*.
|
3b
|
Amended
and Restated Bylaws of Rogers Corporation, effective February 21,
2007
filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed
on February 22, 2007*.
|
4a
|
1997
Shareholder Rights Plan was filed on Form 8-A dated March 24, 1997.
The
June 19, 1997 and July 7, 1997 amendments were filed on Form 8-A/A
dated
July 21, 1997. The April 10, 2000 amendment was filed on Form 8-K
on May
16, 2000*.
|
4b
|
Certain
Long-Term Debt Instruments, each representing indebtedness in an
amount
equal to less than 10 percent of the Registrant’s total consolidated
assets, have not been filed as exhibits to this report on Form 10-Q.
The
Registrant hereby undertakes to file these instruments with the Commission
upon request.
|
4c
|
Shareholder
Rights Agreement, dated as of February 22, 2007, between Rogers
Corporation and Registrar and Transfer Company, as Rights Agent,
filed as
Exhibit 4.1 to the Registrant’s Current Report on form 8-K filed on
February 23, 2007*.
|
10r-7
|
Amendment
No. 7 to Summary of Director and Executive Officer Compensation**,
filed
as Exhibit 10r-7 to the Registrant’s Annual Report on Form 10-K for the
fiscal year ended December 31, 2006 filed on February 27,
2007*.
|
10r-8
|
Amendment
No. 8 to Summary of Director and Executive Officer Compensation**,
filed
herewith.
|
10aac
|
Form
of Nonqualified Stock Option Agreement (for Key Employees, with vesting)
under the Rogers
Corporation 1990 Stock Option Plan, as amended**,
filed herewith.
|
23.1
|
Consent
of National Economic Research Associates, Inc., filed
herewith.
|
23.2
|
Consent
of Marsh U.S.A., Inc., filed herewith.
|
31(a)
|
Certification
of President and Chief Executive Officer pursuant to Rule 13a-14(a)
of the
Securities Exchange Act of 1934, as adopted pursuant to Section 302
of the
Sarbanes-Oxley Act of 2002, filed herewith.
|
31(b)
|
Certification
of Vice President, Finance and Chief Financial Officer Pursuant to
Rule
13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant
to
Section 302 of the Sarbanes-Oxley Act of 2002, filed
herewith.
|
32
|
Certification
of President and Chief Executive Officer and Vice President, Finance
and
Chief Financial Officer Pursuant to Rule 13a-14(b) of the Securities
Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant
to
Section 906 of the Sarbanes-Oxley Act of 2002, filed
herewith.
|
*
|
In
accordance with Rule 12b-23 and Rule 12b-32 under the Securities
Exchange
Act of 1934, as amended, reference is made to the documents previously
filed with the Securities and Exchange Commission, which documents
are
hereby incorporated by reference.
|
**
|
Management
Contract.
|
/s/
Dennis M. Loughran
|
/s/
Paul B. Middleton
|
|
Dennis
M. Loughran
Vice
President, Finance and Chief Financial Officer
Principal
Financial Officer
|
Paul
B. Middleton
Corporate
Controller
Principal
Accounting Officer
|